EPIFENAC

This brand name is authorized in Nigeria.

Active ingredients

The drug EPIFENAC contains one active pharmaceutical ingredient (API):

1	Diclofenac UNII QTG126297Q - DICLOFENAC SODIUM
	Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.
	Read more about Diclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-1734	Eye drops	EPIFENAC EYE DROP SOL_DROPS 1 mg/mL	EPIFENAC EYE DROP DICLOFENAC SODIUM 1MG/ML Diclofenac sodium 1mg, Benzalkonium chloride 0.01%, disodium edetate, boric acid, hydroxylpropyl B- cyclodextrin, sterile water B4-1734 Drugs Imported Products 5ML Prescription Only Medicine (POM) 15/05/2019 EL-MARINE PHARMACEUTICALS LIMITED, OLASIDE CLOSE, OFF IJAOLA STREET, ONIGBONGBO, MARYLAND, LAGOS IKEJA LAGOS 8022976996 pharmelmarine@gmail.com EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO, 10TH OF RAMADAN CITY, INDUSTRIAL AREA B1, CAIRO EGYPT. Business Address :10TH OF RAMADAN CITY, INDUSTRIAL AREA B1, CAIRO EGYPT, Egypt	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BC03	Diclofenac	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids
Discover more medicines within S01BC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-1734